Articaine Hydrochloride Patent Expiration

Articaine Hydrochloride was first introduced by American Genomics Llc in its drug Cyklx on Aug 15, 2025.


Articaine Hydrochloride Patents

Given below is the list of patents protecting Articaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

NEW
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Cyklx US11096922 Anesthetic Composition And Method Of Anesthetizing The Eye Mar 27, 2039 Am Genomics
Cyklx US11826347 Anesthetic Composition And Method Of Anesthetizing The Eye Mar 27, 2039 Am Genomics
Cyklx US12403126 Anesthetic Composition And Method Of Anesthetizing The Eye Mar 27, 2039 Am Genomics



Articaine Hydrochloride's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Articaine Hydrochloride Generic API Manufacturers

Given below is the list of companies who have filed for Articaine Hydrochloride generic, along with the locations of their manufacturing plants worldwide.